Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inmune Bio (INMB) Prepaid Assets (2017 - 2025)

Inmune Bio's Prepaid Assets history spans 9 years, with the latest figure at $472000.0 for Q3 2025.

  • For Q3 2025, Prepaid Assets fell 45.37% year-over-year to $472000.0; the TTM value through Sep 2025 reached $472000.0, down 45.37%, while the annual FY2024 figure was $331000.0, 78.08% down from the prior year.
  • Prepaid Assets for Q3 2025 was $472000.0 at Inmune Bio, down from $505000.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $4.7 million in Q1 2022 and bottomed at $207000.0 in Q1 2025.
  • The 5-year median for Prepaid Assets is $1.5 million (2023), against an average of $2.0 million.
  • The largest annual shift saw Prepaid Assets surged 935.45% in 2021 before it tumbled 81.33% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $2.3 million in 2021, then surged by 76.78% to $4.0 million in 2022, then crashed by 62.5% to $1.5 million in 2023, then plummeted by 78.08% to $331000.0 in 2024, then skyrocketed by 42.6% to $472000.0 in 2025.
  • Per Business Quant, the three most recent readings for INMB's Prepaid Assets are $472000.0 (Q3 2025), $505000.0 (Q2 2025), and $207000.0 (Q1 2025).